SCHEMBL7064260

SCHEMBL7064260

CCCc1nn(S(C)(=O)=O)c(O)c1C(=O)c1cccnc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 3/20 0.38
TSHR P16473 2/20 0.38
LMNA P02545 2/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
GAA P10253 3/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GRM2 Q14416 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TRPV1 Q8NER1 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2214214 0.83 ALDH1A1 (0.43) L3MBTL1ALDH1A1TSHRLMNAHDAC3
SCHEMBL6919541 0.82 HTT (0.41) L3MBTL1ALDH1A1TSHRLMNAHDAC3
SCHEMBL6919885 0.77 GAA (0.40) MAPK1L3MBTL1ALDH1A1LMNAHDAC3
SCHEMBL6919835 0.77 L3MBTL1 (0.47) L3MBTL1ALDH1A1TSHRLMNAHDAC3
SCHEMBL6919643 0.76 L3MBTL1 (0.46) L3MBTL1ALDH1A1TSHRLMNAHDAC3
SCHEMBL6918282 0.73 ALDH1A1 (0.42) L3MBTL1ALDH1A1TSHRLMNAHDAC3
SCHEMBL6922174 0.72 MAPT (0.43) MAPK1L3MBTL1ALDH1A1TSHRLMNA
SCHEMBL6919131 0.68 ALDH1A1 (0.40) L3MBTL1ALDH1A1GAAMAPTHTT
SCHEMBL6922367 0.68 HTT (0.40) L3MBTL1ALDH1A1TSHRLMNAGAA
SCHEMBL6921278 0.68 TSHR (0.46) MAPK1L3MBTL1ALDH1A1TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004033431-A2 HYDROXYPYRAZOLES FOR USE AGAINST METABOLIC-RELATED DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2004-04-22 WO disclosed